2001 Review: Biotechs Talk Turkey

In the days after biotech giant Amgen(AMGN Quote) announced its $16 billion takeover of Immunex(IMNX Quote), there was a rush to proclaim that a new wave of merger and acquisition activity was about to roil the biotech sector.

Wall Street Winces

Big Funds Come Up Big

Restoration Hardware Shakes Off the Dust

Five Stocks That Came Out of Nowhere

Stocks Stuck in the Back Seat

Four CEOs Who Slipped Through the Net

After all, the Amgen-Immunex deal was preceded by two other big transactions in December -- Millennium Pharmaceuticals' $2 billion purchase of Cor Therapeutics(CORR Quote), and Medimmune's(MEDI Quote) $1 billion acquisition of Aviron(AVIR Quote). ...